Dr. Mark Tullman discusses results of key clinical trials presented at the 60th annual AAN meeting on currently available disease-modifying therapies for MS and the potential implications. Medscape Neurology & Neurosurgery
A meta-analysis examining the efficacy of second-generation antipsychotics in the treatment of schizophrenia shows there are small differences, suggesting other factors, including adverse effects and cost, should be considered in treatment choice. Medscape Medical News
Results of a case control study show that restless legs syndrome occurs more frequently in patients with migraine, along with an association of depression. Reuters Health Information
